Macrogenics Inc (MGNX)
3.265
+0.06
(+1.71%)
USD |
NASDAQ |
Nov 22, 10:24
Macrogenics Total Liabilities (Quarterly): 144.43M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 144.43M |
| June 30, 2024 | 143.32M |
| March 31, 2024 | 142.13M |
| December 31, 2023 | 145.80M |
| September 30, 2023 | 145.99M |
| June 30, 2023 | 134.11M |
| March 31, 2023 | 234.23M |
| December 31, 2022 | 138.46M |
| September 30, 2022 | 72.39M |
| June 30, 2022 | 75.56M |
| March 31, 2022 | 93.23M |
| December 31, 2021 | 95.63M |
| September 30, 2021 | 100.72M |
| June 30, 2021 | 106.87M |
| March 31, 2021 | 84.91M |
| December 31, 2020 | 82.86M |
| September 30, 2020 | 82.80M |
| June 30, 2020 | 79.81M |
| March 31, 2020 | 74.84M |
| December 31, 2019 | 81.87M |
| September 30, 2019 | 96.25M |
| June 30, 2019 | 89.23M |
| March 31, 2019 | 94.02M |
| December 31, 2018 | 89.25M |
| Date | Value |
|---|---|
| September 30, 2018 | 72.71M |
| June 30, 2018 | 74.86M |
| March 31, 2018 | 78.80M |
| December 31, 2017 | 74.64M |
| September 30, 2017 | 52.38M |
| June 30, 2017 | 43.50M |
| March 31, 2017 | 40.08M |
| December 31, 2016 | 42.51M |
| September 30, 2016 | 39.76M |
| June 30, 2016 | 38.87M |
| March 31, 2016 | 39.40M |
| December 31, 2015 | 45.93M |
| September 30, 2015 | 44.76M |
| June 30, 2015 | 42.51M |
| March 31, 2015 | 47.08M |
| December 31, 2014 | 52.60M |
| September 30, 2014 | 54.54M |
| June 30, 2014 | 63.74M |
| March 31, 2014 | 56.95M |
| December 31, 2013 | 46.87M |
| September 30, 2013 | 46.02M |
| June 30, 2013 | 53.11M |
| December 31, 2012 | 61.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
72.39M
Minimum
Sep 2022
234.23M
Maximum
Mar 2023
113.00M
Average
98.17M
Median
Total Liabilities (Quarterly) Benchmarks
| KORU Medical Systems Inc | 9.657M |
| Apellis Pharmaceuticals Inc | 664.74M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.49M |
| Shareholders Equity (Quarterly) | 120.07M |
| Current Ratio | 3.746 |